rofecoxib has been researched along with Anterior Choroidal Artery Infarction in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " cerebral infarction, myocardial infarction and unstable angina pectoris, among rofecoxib and naproxen users in comparison to diclofenac users." | 3.76 | Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. ( Einarsdottir, R; Gudbjornsson, B; Halldorsson, M; Johannsson, M; Sigvaldason, H; Thorgeirsson, G; Thorsteinsson, SB; Zoega, H, 2010) |
| "To evaluate the site of action cerebral infarcted rats underwent single intracerebroventricular or intrathecal administration of FYO-750." | 1.36 | Improvement in neurogenic detrusor overactivity by peripheral C fiber's suppression with cyclooxygenase inhibitors. ( Akino, H; Aoki, Y; Nagase, K; Tanaka, I; Tanase, K; Yokoyama, O, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, I | 1 |
| Nagase, K | 1 |
| Tanase, K | 1 |
| Aoki, Y | 1 |
| Akino, H | 1 |
| Yokoyama, O | 1 |
| Gudbjornsson, B | 1 |
| Thorsteinsson, SB | 1 |
| Sigvaldason, H | 1 |
| Einarsdottir, R | 1 |
| Johannsson, M | 1 |
| Zoega, H | 1 |
| Halldorsson, M | 1 |
| Thorgeirsson, G | 1 |
| Frantz, S | 1 |
| Aizen, E | 1 |
| Kagan, G | 1 |
| Assy, B | 1 |
| Iobel, R | 1 |
| Bershadsky, Y | 1 |
| Gilhar, A | 1 |
| Palmer, K | 1 |
| Sawicki, PT | 1 |
| Bender, R | 1 |
| Selke, GW | 1 |
| Klauber, J | 1 |
| Gutschmidt, S | 1 |
1 trial available for rofecoxib and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cerebral | 2005 |
5 other studies available for rofecoxib and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Improvement in neurogenic detrusor overactivity by peripheral C fiber's suppression with cyclooxygenase inhibitors.
Topics: Animals; Cerebral Infarction; Cyclooxygenase Inhibitors; Female; Lactones; Nerve Fibers, Unmyelinate | 2010 |
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.
Topics: Angina, Unstable; Celecoxib; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Databases, Factual; D | 2010 |
How to avoid another 'Vioxx'.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cerebral Infarction; Clinical Trials as Topic; Cyclooxygena | 2005 |
The Vioxx fallout.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumat | 2005 |
[Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004].
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cerebral Infarction; Clinical Trials as Topic; Cross | 2006 |